Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Association between Race and Social Deprivation in Patients with Hematologic Malignancies

Emmanuella Kobara, Michael Cottone, Mohammed Shah, Shahidul Islam, Marc Braunstein

Blood (2023) 142 (Supplement 1): 7369.

https://doi.org/10.1182/blood-2023-189170

Published: 2023

Journal Articles

Young and Distinct: Clinical Characteristics and Outcomes of Patients 50 or Younger with Multiple Myeloma

Andrea Tufano-Sugarman, Shahidul Islam, Faith E. Davies, Gareth J. Morgan, David Kaminetzky, Marc Braunstein

Blood (2023) 142 (Supplement 1): 6684.

https://doi.org/10.1182/blood-2023-182954

Published: 2023

Journal Articles

Whole-Genome Sequencing Identifies Structural Variation As a Key Driver of Disease Relapse and Aggressive Clinical Behavior in Multiple Myeloma

Marc Braunstein, Patrick Blaney, Gareth J. Morgan

Blood (2023) 142 (Supplement 1): 2773.

https://doi.org/10.1182/blood-2023-191008

Published: 2023

Journal Articles

Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin

Blood (2022) 140 (Supplement 1): 430–432.

https://doi.org/10.1182/blood-2022-167390

Published: 2022

Journal Articles

Structural Heterogeneity of Chromosome 1q Drives Outcome in Newly Diagnoses Myeloma

Blood (2022) 140 (Supplement 1): 4253–4254.

https://doi.org/10.1182/blood-2022-165467

Published: 2022

Journal Articles

Unifying the Definition of High-Risk in Multiple Myeloma

Blood (2021) 138 (Supplement 1): 2714.

https://doi.org/10.1182/blood-2021-148502

Published: 2021

Journal Articles

Hispanic or Latin American Ancestry Is Associated with a Similar Genomic Profile and a Trend Toward Inferior Outcomes in Newly Diagnosed Multiple Myeloma As Compared to Non-Hispanic White Patients in the Multiple Myeloma Research Foundation (MMRF) CoMMpassstudy

Louis Williams, Patrick Blaney, Eileen M Boyle, Hussein Ghamlouch, Yubao Wang, Jinyoung Choi, Michael A Bauer, Ariel Siegel, James Stoeckle, Beatrice Razzo, Daniel Auclair, David Kaminetzky, Marc Braunstein, Benedetto Bruno, Arnaldo A. Arbini, Brian A Walker, Faith E. Davies, Gareth J Morgan

Blood (2021) 138 (Supplement 1): 4117.

https://doi.org/10.1182/blood-2021-148854

Published: 2021

Journal Articles

Multiomic Mapping of Copy Number and Structural Variation on Chromosome 1 (Chr1) Highlights Multiple Recurrent Disease Drivers

Blood (2021) 138 (Supplement 1): 721.

https://doi.org/10.1182/blood-2021-148439

Published: 2021

Journal Articles

Influence of Aging Processes on the Biology and Outcome of Multiple Myeloma

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-138787

Published: 2020

Journal Articles

Association between Clinical Presentation of Multiple Myeloma, Immunoglobulin Isotypes, and Cytogenetic Risk Groups

Ramya Muddasani, DO, Angela Ramdhanny, MD, Gabriel Lutz, MD PhD, Albert Ho, MDPhD, Meredith Akerman, PhD, Mitchel Polak, Marc Braunstein, MDPhD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-135981

Published: 2020

Journal Articles

Outcomes of Patients with Hematologic Malignancies Who Received Inpatient Palliative Care Consultation

Anthony Vito Pasquarella, MD, Angela Ramdhanny, MD, Mina Gendy, DO, Priya Pinto, MD, Shahidul Islam, DrPH, MPH, PStat, Marc Braunstein, MDPhD

Blood (2020) 136 (Supplement 1): 46.

https://doi.org/10.1182/blood-2020-139023

Published: 2020

Journal Articles

Retrospective Assessment of Outcomes Following Superficial Vein Thrombosis in Cancer Patients

Mina Gendy, DO, Marie Anne Christine Buteau, MD, Marc Braunstein, MD PhD

Blood (2019) 134 (Supplement_1): 3655.

https://doi.org/10.1182/blood-2019-131978

Published: 2019

Journal Articles

Analysis of Intestinal Microbiome in Multiple Myeloma Reveals Progressive Dysbiosis Compared to MGUS and Healthy Individuals

Crystal Antoine Pepeljugoski, MD, Gareth Morgan, MD PhD, Marc Braunstein, MD PhD

Blood (2019) 134 (Supplement_1): 3076.

https://doi.org/10.1182/blood-2019-130643

Published: 2019

Journal Articles

Association between Immunoglobulin Isotypes and Cytogenetic Risk Groups in Multiple Myeloma

Ramya Muddasani, DO, Albert Ho, MD PhD, Meredith Akerman, PhD, Shahidul Islam, MPH, PStat, Mitchel Polak, Jamie Andres Suarez-Londono, MD, Marc Braunstein, MD PhD

Blood (2018) 132 (Supplement 1): 5585.

https://doi.org/10.1182/blood-2018-99-118831

Published: 2018

Journal Articles

Analysis of the IgA Heavy Chain Repertoire in Multiple Myeloma: Implications for Host-Microbiome Influences

Marc Braunstein, MD PhD, Hanane El Bannoudi, PhD, Maher Abdul Hay, MD, Sergei L.K. Pond, PhD, Gregg J. Silverman, MD

Blood (2017) 130 (Supplement 1): 3033.

https://doi.org/10.1182/blood.V130.Suppl_1.3033.3033

Published: 2017

Journal Articles

Neutropenic Enterocolitis in Adult Patients with Acute Leukemia: A Single Center Experience

Reena K. Vora, MD, Marc Braunstein, MD, Jae Cho, MD, Martin L. Lesser, PhD, Eran Ben-Levi, MD, Thomas P. Bradley, MD, Steven L. Allen, MD, Jonathan E. Kolitz, MD

Blood (2012) 120 (21): 4324.

https://doi.org/10.1182/blood.V120.21.4324.4324

Published: 2012

Journal Articles

Clonal Restriction in Endothelial Progenitor Cells in Patients with Multiple Myeloma.

Marc Braunstein, BS, Tayfun Özçelik, MD, Sevgi Bagislar, Varsha Vakil, Eric L.P. Smith, PhD, Olcay Batuman, MD

Blood (2005) 106 (11): 2496.

https://doi.org/10.1182/blood.V106.11.2496.2496

Published: 2005

Journal Articles

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Low-Dose Thalidomide in Combination with Dexamethasone and Zoledronate: A Phase II Trial.

Uwe Klueppelberg, MD, PhD, Iuliana Shapira, MD, Eric Smith, PhD, Marc Braunstein, BS, David Kahn, MD, Yury Pertsovsky, Olcay Batuman, MD

Blood (2005) 106 (11): 5180.

https://doi.org/10.1182/blood.V106.11.5180.5180

Published: 2005

Journal Articles

Circulating endothelial progenitor cells in multiple myeloma: implications and significance

Hong Zhang, Varsha Vakil, Marc Braunstein, Eric L. P. Smith, Justin Maroney, Laurie Chen, Kezhi Dai, James R. Berenson, M. Mahmood Hussain, Uwe Klueppelberg, Allen J. Norin, Hasan O. Akman, Tayfun Özçelik, Olcay A. Batuman

Blood (2005) 105 (8): 3286–3294.

https://doi.org/10.1182/blood-2004-06-2101

Published: 2005

Journal Articles

Evidence for Clonality in Circulating Endothelial Progenitor Cells in Multiple Myeloma.

Tayfun Ozcelik, MD, Varsha Vakil, Eric Smith, PhD, Marc Braunstein, Justin Maroney, Uwe Klueppelberg, MD PhD, Sevgi Bagislar, Cemaliye Akyerli, Olcay Batuman, MD

Blood (2004) 104 (11): 2357.

https://doi.org/10.1182/blood.V104.11.2357.2357

Published: 2004

NARROW

Association between Race and Social Deprivation in Patients with Hematologic Malignancies

Young and Distinct: Clinical Characteristics and Outcomes of Patients 50 or Younger with Multiple Myeloma

Whole-Genome Sequencing Identifies Structural Variation As a Key Driver of Disease Relapse and Aggressive Clinical Behavior in Multiple Myeloma

Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin

Structural Heterogeneity of Chromosome 1q Drives Outcome in Newly Diagnoses Myeloma

Unifying the Definition of High-Risk in Multiple Myeloma

Hispanic or Latin American Ancestry Is Associated with a Similar Genomic Profile and a Trend Toward Inferior Outcomes in Newly Diagnosed Multiple Myeloma As Compared to Non-Hispanic White Patients in the Multiple Myeloma Research Foundation (MMRF) CoMMpassstudy

Multiomic Mapping of Copy Number and Structural Variation on Chromosome 1 (Chr1) Highlights Multiple Recurrent Disease Drivers

Influence of Aging Processes on the Biology and Outcome of Multiple Myeloma

Association between Clinical Presentation of Multiple Myeloma, Immunoglobulin Isotypes, and Cytogenetic Risk Groups

Outcomes of Patients with Hematologic Malignancies Who Received Inpatient Palliative Care Consultation

Retrospective Assessment of Outcomes Following Superficial Vein Thrombosis in Cancer Patients

Analysis of Intestinal Microbiome in Multiple Myeloma Reveals Progressive Dysbiosis Compared to MGUS and Healthy Individuals

Association between Immunoglobulin Isotypes and Cytogenetic Risk Groups in Multiple Myeloma

Analysis of the IgA Heavy Chain Repertoire in Multiple Myeloma: Implications for Host-Microbiome Influences

Neutropenic Enterocolitis in Adult Patients with Acute Leukemia: A Single Center Experience

Clonal Restriction in Endothelial Progenitor Cells in Patients with Multiple Myeloma.

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Low-Dose Thalidomide in Combination with Dexamethasone and Zoledronate: A Phase II Trial.

Circulating endothelial progenitor cells in multiple myeloma: implications and significance

Evidence for Clonality in Circulating Endothelial Progenitor Cells in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only